Clinical Trial

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the bioavailability, mass balance, pharmacokinetics, metabolism and excretion of radiolabeled (14C) VH4524184.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-03
Trial Details
NCT Number NCT07636928
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 9 participants
Start Date 2026-06-04
Primary Completion 2026-08-20 (estimated)
Study Completion 2026-08-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-02